Skip to main content

Table 6 Multivariate analysis of the predictors for the 30-day mortality

From: Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii

Variables

Adjusted OR (95% CI)

p

CURB65 score

3.18 (1.44–6.99)

0.004

Mechanical ventilation

6.38 (1.16–35.23)

0.034

Bacteremia

21.00 (0.99–443.40)

0.050

Duration of Tigecycline treatment

0.97 (0.87–1.08)

0.567

Tigecycline resistance

0.20 (0.05–0.78)

0.021

  1. Abbreviations: OR odd ratio, CI confidence interval, MDRAB multidrugresistant Acinetobacter baumannii
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us